Aug 26, 2021 · 29 min
Business
The Readout Loud
STAT
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
- 416 episodes
- Updated Thursday
Episodes416
Aug 19, 2021 · 28 minEpisode 174: Biotech's trust issues, overwhelmed health workers, & the nuances of insider trading
Aug 12, 2021 · 30 minEpisode 173: Biden's drug pricing plan, Wall Street's Alzheimer's fixation, & daily 5 a.m. alarms
Aug 5, 2021 · 33 minEpisode 172: The mRNA gold rush, Delta's alarming rise, & the next treatment for Alzheimer's
Jul 29, 2021 · 34 minEpisode 171: The quest for a Covid pill, a microbiome gut-check, & CRISPR on the big screen
Jul 22, 2021 · 32 minEpisode 170: Céline Gounder on breakthrough infections, plus the power of lobbying
Jul 15, 2021 · 30 minEpisode 169: Dan Diamond on covering Biden, plus the FDA's future, & the latest Aduhelm twist
Jul 8, 2021 · 31 minEpisode 168: Aduhelm's latest twist, & how Covid variants are shaping the summer
Jul 1, 2021 · 43 minEpisode 167: George Yancopoulos on biotech in 2021, plus a CRISPR milestone, Biogen's FDA saga,
Jun 24, 2021 · 37 minEpisode 166: FDA inner workings, GSK's foggy future, & the alarming rise in colorectal cancer
Jun 17, 2021 · 34 minEpisode 165: Paul Offit on the Covid vaccine booster debate, & Robyn Karnauskas' call of the decade
Jun 10, 2021 · 40 minEpisode 164: Every angle on the FDA's polarizing approval of Biogen's Alzheimer's drug
Jun 3, 2021 · 28 minEpisode 163: Marilynn Marchione on covering the CRISPR babies scandal
May 27, 2021 · 32 minEpisode 162: Scott Gottlieb on Covid and grilling, plus how Zolgensma has changed SMA
May 20, 2021 · 38 minEpisode 161: Biotech meme stocks, the lessons of Spanish Flu, & becoming a pandemic celebrity
May 13, 2021 · 29 minEpisode 160: Global Covid-19 failures, a sluggish CDC, and a boisterous STAT Health Tech Summit
May 6, 2021 · 33 minEpisode 159: Thomas Bollyky on patent waivers, plus vaccine riches, & a gene therapy for aging
Apr 29, 2021 · 28 minEpisode 158: Angela Rasmussen on Russia's vaccine controversy, plus Biden's drug pricing punt
Apr 22, 2021 · 33 minEpisode 157: Mercedes Carnethon on outdoor masking, FDA in limbo, & gene therapy's uncertain upside
Apr 15, 2021 · 30 minEpisode 156: J&J's vaccine pause, talking about remote risks, & why no new drugs for Covid-19